Neuroprotective and Cardioprotective Effects Of Palm Vitamin E Tocotrienols

PHASE2CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Cerebrovascular Disorders
Interventions
DIETARY_SUPPLEMENT

200mg of Palm vitamin E (tocotrienols) or placebo

Individuals randomized in the (MRI+ve) and (MRI -ve) cohort respectively. In the MRI(+ve) cohort, 62 subjects received 200 mg softgels of Palm Vitamin E (tocotrienols) and 59 were assigned to placebo, taken orally twice a day for a study period of two years. In the MRI(-ve) cohort, 63 subjects received 200 mg softgels of Palm Vitamin E (tocotrienols) and 57 consumed placebo, taken twice a day for a follow up period of 1 year.

Trial Locations (1)

13200

Kepala Batas Hospital, Kepala Batas

All Listed Sponsors
collaborator

Malaysia Palm Oil Board

OTHER_GOV

lead

Universiti Sains Malaysia

OTHER

NCT00753532 - Neuroprotective and Cardioprotective Effects Of Palm Vitamin E Tocotrienols | Biotech Hunter | Biotech Hunter